ArticleJournal of translational medicine2023

Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study.

Sabrina Pagano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.